Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jarett L. Feldman, Michael J. Morris, Scott T. Tagawa, David M. Nanus, Stephen Barnett Solomon, Jorge A. Carrasquillo, Victor E. Reuter, Jason Stuart Lewis, Joseph A. O' Donoghue, Danny F. Martinez, Susan F. Slovin, Dana E. Rathkopf, Mithat Gonen, Volkan Beylergil, Jeremy C. Durack, Sarah M. Cheal, Neil Harrison Bander, Howard I. Scher, Steven M. Larson, Neeta Pandit-Taskar
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4240611357
